The Impact of Hemoglobin Level and Transfusion on the Outcomes of Chemotherapy in Gastric Cancer Patients

Overview

Journal Int J Clin Exp Med

Specialty General Medicine

Date 2015 Jun 12

PMID 26064334

Citations 13

Authors

Xianren Ye

Jingfu Liu

Yujuan Chen

Na Wang

Rong Lu

Affiliations

Soon will be listed here.

Abstract

Objective: To examine the impact of hemoglobin levels in predicting outcomes and evaluate whether transfusion could improve the outcomes of chemotherapy on gastric cancer patients.

Methods: A total 310 patients were divided into two groups: high Hb group (Hb >90 g/L) and low Hb group (Hb <90 g/L). A portion of patients in low Hb group received transfusion. The effect of hemoglobin level on the chemotherapy outcomes was determined according to the comparison between patients with high hemoglobin and patients with low hemoglobin without transfusion. The effect of transfusion on the chemotherapy outcomes was evaluated by comparing the two low groups (with and without transfusion).

Results: A total of 310 patients were within the study criteria. Among them, 27.7% patients in high Hb group, 44.5% patients in low Hb without transfusion and 27.7% patients in low Hb with transfusion were followed up. The 5-years survival rates of high Hb group, low Hb group without transfusion and with transfusion were respectively 29%, 10% and 8%. The survival rate of patients in Hb group without transfusion was higher. The chemotherapy rates of patients in high Hb group, low Hb without transfusion group and with transfusion group were respectively 32.56%, 42.03% and 18.6%.

Conclusion: Low nadir Hb (<90 g/L) during chemotherapy had an effect on the survival and chemotherapy response rate. The chemotherapy outcomes could not be improved through increasing Hb level by red blood cell (RBC) transfusion.

Citing Articles

Relationships between nutritional status and serum adipokine levels with chemotherapy efficacy in late-stage colorectal cancer patients.

Zhang W, Wang S Int J Colorectal Dis. 2025; 40(1):25.

PMID: 39873770 PMC: 11775029. DOI: 10.1007/s00384-024-04791-9.

Assessing the Predictive Power of the Hemoglobin/Red Cell Distribution Width Ratio in Cancer: A Systematic Review and Future Directions.

Coradduzza D, Medici S, Chessa C, Zinellu A, Madonia M, Angius A Medicina (Kaunas). 2023; 59(12).

PMID: 38138227 PMC: 10744746. DOI: 10.3390/medicina59122124.

Prognostic Significance of Hemoglobin/Prognostic Nutritional Index and Hemoglobin/Red Blood Cell Distribution in Rectal Cancer.

Tuncel E, Parvizi M, Kut E, Aydin M, Kasap E Turk J Gastroenterol. 2022; 34(2):128-134.

PMID: 36511609 PMC: 10081009. DOI: 10.5152/tjg.2022.22203.

A Knowledge-Based Discovery Approach Couples Artificial Neural Networks With Weight Engineering to Uncover Immune-Related Processes Underpinning Clinical Traits of Breast Cancer.

Zhang C, Correia C, Weiskittel T, Tan S, Meng-Lin K, Yu G Front Immunol. 2022; 13:920669.

PMID: 35911770 PMC: 9330471. DOI: 10.3389/fimmu.2022.920669.

Irregular delay of adjuvant chemotherapy correlated with poor outcome in stage II-III colorectal cancer.

Chen Y, Xu M, Ye Q, Xiang J, Xue T, Yang T BMC Cancer. 2022; 22(1):670.

PMID: 35715761 PMC: 9206266. DOI: 10.1186/s12885-022-09767-y.

References

Craig S, Adam D, Yap P, Leaver H, Elton R, Cameron E . Effect of blood transfusion on survival after esophagogastrectomy for carcinoma. Ann Thorac Surg. 1998; 66(2):356-61. DOI: 10.1016/s0003-4975(98)00460-3. View

Park S, Nam E, Bang S, Cho E, Shin D, Lee J . A randomized trial of anemia correction with two different hemoglobin targets in the first-line chemotherapy of advanced gastric cancer. Cancer Chemother Pharmacol. 2007; 62(1):1-9. DOI: 10.1007/s00280-007-0561-1. View

Caro J, Salas M, Ward A, Goss G . Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review. Cancer. 2001; 91(12):2214-21. View

Schafer U, Micke O, Muller S, Schuller P, Willich N . Hemoglobin as an independent prognostic factor in the radiotherapy of head and neck tumors. Strahlenther Onkol. 2003; 179(8):527-34. DOI: 10.1007/s00066-003-1117-x. View

Montgomery J, Syed M, Rana I, Singh J, Clark L . Hemoglobin monitoring in head and neck cancer patients undergoing radiotherapy. Ann Otol Rhinol Laryngol. 2010; 119(7):472-5. DOI: 10.1177/000348941011900708. View

Ohtsu A, Shimada Y, Shirao K, Boku N, Hyodo I, Saito H . Randomized phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable, advanced gastric cancer: The Japan Clinical Oncology Group Study (JCOG9205). J Clin Oncol. 2002; 21(1):54-9. DOI: 10.1200/JCO.2003.04.130. View

Scott S, Boeve T, McCulloch T, Fitzpatrick K, Karnell L . The effects of epoetin alfa on transfusion requirements in head and neck cancer patients: a prospective, randomized, placebo-controlled study. Laryngoscope. 2002; 112(7 Pt 1):1221-9. DOI: 10.1097/00005537-200207000-00015. View

Steup W, Hojo K, Moriya Y, Sugihara K, Mizuno S, Hermans J . An analysis on the effect of blood transfusion on recurrence and survival in patients undergoing extended lymphadenectomy for colorectal cancer. Hepatogastroenterology. 1994; 41(3):253-9. View

Hill R, Bush R, Yeung P . The effect of anaemia on the fraction of hypoxic cells in an experimental tumour. Br J Radiol. 1971; 44(520):299-304. DOI: 10.1259/0007-1285-44-520-299. View

10.

Dangsuwan P, Manchana T . Blood transfusion reduction with intravenous iron in gynecologic cancer patients receiving chemotherapy. Gynecol Oncol. 2010; 116(3):522-5. DOI: 10.1016/j.ygyno.2009.12.004. View

11.

Bush R, Jenkin R, Allt W, Beale F, BEAN H, Dembo A . Definitive evidence for hypoxic cells influencing cure in cancer therapy. Br J Cancer Suppl. 1978; 3:302-6. PMC: 2149436. View

12.

Hoff C, Lassen P, Eriksen J, Sand Hansen H, Specht L, Overgaard M . Does transfusion improve the outcome for HNSCC patients treated with radiotherapy? - results from the randomized DAHANCA 5 and 7 trials. Acta Oncol. 2011; 50(7):1006-14. DOI: 10.3109/0284186X.2011.592650. View

13.

Hoff C . Importance of hemoglobin concentration and its modification for the outcome of head and neck cancer patients treated with radiotherapy. Acta Oncol. 2012; 51(4):419-32. DOI: 10.3109/0284186X.2011.653438. View

14.

Barrett-Lee P, Bailey N, OBrien M, Wager E . Large-scale UK audit of blood transfusion requirements and anaemia in patients receiving cytotoxic chemotherapy. Br J Cancer. 2000; 82(1):93-7. PMC: 2363194. DOI: 10.1054/bjoc.1999.0883. View

15.

Rades D, Stoehr M, Kazic N, Hakim S, Walz A, Schild S . Locally advanced stage IV squamous cell carcinoma of the head and neck: impact of pre-radiotherapy hemoglobin level and interruptions during radiotherapy. Int J Radiat Oncol Biol Phys. 2007; 70(4):1108-14. DOI: 10.1016/j.ijrobp.2007.07.2380. View

16.

Dubray B, Mosseri V, Brunin F, Jaulerry C, Poncet P, Rodriguez J . Anemia is associated with lower local-regional control and survival after radiation therapy for head and neck cancer: a prospective study. Radiology. 1996; 201(2):553-8. DOI: 10.1148/radiology.201.2.8888257. View

17.

Rizzo J, Somerfield M, Hagerty K, Seidenfeld J, Bohlius J, Bennett C . Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update. J Clin Oncol. 2007; 26(1):132-49. DOI: 10.1200/JCO.2007.14.3396. View

18.

Obermair A, Cheuk R, Horwood K, Janda M, Bachtiary B, Schwanzelberger B . Impact of hemoglobin levels before and during concurrent chemoradiotherapy on the response of treatment in patients with cervical carcinoma: preliminary results. Cancer. 2001; 92(4):903-8. DOI: 10.1002/1097-0142(20010815)92:4<903::aid-cncr1399>3.0.co;2-2. View

19.

Park S, Lee J, Lee S, Park J, Kim K, Kim W . Anemia is the strongest prognostic factor for outcomes of 5-fluorouracil-based first-line chemotherapy in patients with advanced gastric cancer. Cancer Chemother Pharmacol. 2005; 57(1):91-6. DOI: 10.1007/s00280-005-0027-2. View

20.

Fong Y, Karpeh M, Mayer K, Brennan M . Association of perioperative transfusions with poor outcome in resection of gastric adenocarcinoma. Am J Surg. 1994; 167(2):256-60. DOI: 10.1016/0002-9610(94)90087-6. View